142 related articles for article (PubMed ID: 28978463)
21. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
Coyle K; Carrier M; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Coyle D
Thromb Res; 2017 Mar; 151():67-71. PubMed ID: 28160670
[TBL] [Abstract][Full Text] [Related]
22. Extensive screening for occult malignancy in unprovoked venous thromboembolism: A meta-analysis.
Zhou M; Zhang L; Ding Y; Wang Y; Yan D; Lin C; Shi Z; Fu W
Thromb Res; 2017 Sep; 157():147-153. PubMed ID: 28753478
[TBL] [Abstract][Full Text] [Related]
23. Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions.
Patel SS; Tao D; McMurry HS; Shatzel JJ
Eur J Haematol; 2023 Jan; 110(1):24-31. PubMed ID: 36192850
[TBL] [Abstract][Full Text] [Related]
24. Occult cancer detection in patients with hemostatic disorder and venous thromboembolism.
Husseinzadeh H; Carrier M
Thromb Res; 2018 Mar; 163():242-245. PubMed ID: 28587726
[TBL] [Abstract][Full Text] [Related]
25. Investigation of unprovoked venous thromboembolism: a case for a tempered approach?
Hussain TI; Stephenson JA; Das B; Naqvi S; Verma R; Barnes D
Clin Radiol; 2016 Oct; 71(10):1005-1009. PubMed ID: 27237325
[TBL] [Abstract][Full Text] [Related]
26. Unprovoked venous thromboembolism in women over 40: is screening for occult malignancy with mammography and abdominopelvic CT of benefit?
Healy NA; Daley FC; Sinnatamby R
Clin Radiol; 2020 Oct; 75(10):757-762. PubMed ID: 32646605
[TBL] [Abstract][Full Text] [Related]
27. Implementation of NICE recommendations on abdomino-pelvic CT, following unprovoked venous thromboembolism, in a UK teaching hospital: no additional detection of occult malignancy and high numbers of incidental findings.
Garwood D; Renton BJ; Joekes E
Acute Med; 2016; 15(5):25-9. PubMed ID: 27116584
[TBL] [Abstract][Full Text] [Related]
28. [The occurrence of occult malignancy in patients less than 50 years of age with venous thromboembolism: which diagnostic screening methods to use?].
Malý R; Vodicková L
Vnitr Lek; 2004 Oct; 50(10):751-5. PubMed ID: 15633930
[TBL] [Abstract][Full Text] [Related]
29. CT imaging for occult malignancy in patients with unprovoked venous thromboembolism (VTE) in a tertiary centre: is it worthwhile?
Lee RJ; Herlihy D; O'Neill DC; Madden-Doyle L; Morrin M; Lee MJ
Ir J Med Sci; 2023 Dec; 192(6):3081-3086. PubMed ID: 36849651
[TBL] [Abstract][Full Text] [Related]
30. Screening for Occult Cancer in Patients with Venous Thromboembolism.
D'Astous J; Carrier M
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32726911
[TBL] [Abstract][Full Text] [Related]
31. Real-world incidence of cancer following a first unprovoked venous thrombosis: Results from the EPIGETBO study.
Delluc A; Ianotto JC; Tromeur C; De Moreuil C; Couturaud F; Lacut K; Le Moigne E; Louis P; Thereaux J; Metges JP; Mottier D
Thromb Res; 2018 Apr; 164():79-84. PubMed ID: 29522910
[TBL] [Abstract][Full Text] [Related]
32. [Screening for occult cancer in patients with unprovoked venous thromboembolism].
Qiao LS; Xu XM
Zhonghua Jie He He Hu Xi Za Zhi; 2023 May; 46(5):498-502. PubMed ID: 37147813
[TBL] [Abstract][Full Text] [Related]
33. Cancer and venous thrombosis: current comprehensions and future perspectives.
Lauw MN; van Doormaal FF; Middeldorp S; Buller HR
Semin Thromb Hemost; 2013 Jul; 39(5):507-14. PubMed ID: 23629821
[TBL] [Abstract][Full Text] [Related]
34. Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.
Sánchez-López V; Marín-Romero S; Ferrer-Galván M; Elías-Hernández T; Lobo Beristain JL; Ballaz Quincoces A; Jara-Palomares L; Rodríguez Martorell FJ; Castro MJ; Marín Hinojosa C; López-Campos JL; Otero-Candelera R
Am J Clin Pathol; 2024 May; 161(5):501-511. PubMed ID: 38340336
[TBL] [Abstract][Full Text] [Related]
35. The Conundrum of Occult Cancer Screening in Venous Thromboembolism: Lessons from the REMOTEV Registry.
Cordeanu EM; Jambert L; Tousch J; Mirea C; Delatte A; Younes W; Woehl B; Harter C; Frantz AS; Hamade A; Schini-Kerth V; Ohlmann P; Andres E; Stephan D
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888632
[TBL] [Abstract][Full Text] [Related]
36. Occult malignancy in patients with venous thromboembolism: risk indicators and a diagnostic screening strategy.
Oktar GL; Ergul EG; Kiziltepe U
Phlebology; 2007; 22(2):75-9. PubMed ID: 18268854
[TBL] [Abstract][Full Text] [Related]
37. Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score.
Bertoletti L; Robin P; Jara-Palomares L; Tromeur C; Pastre J; Prevot-Bitot N; Mouneh T; Le Gal G; Salaun PY;
J Thromb Haemost; 2017 Nov; 15(11):2184-2187. PubMed ID: 28875565
[TBL] [Abstract][Full Text] [Related]
38. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
39. Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis.
van Es N; Le Gal G; Otten HM; Robin P; Piccioli A; Lécumberri R; Jara-Palomares L; Religa P; Rieu V; Rondina MT; Beckers MM; Prandoni P; Salaun PY; Nisio MD; Bossuyt PM; Büller HR; Carrier M
BMJ Open; 2017 Jun; 7(6):e015562. PubMed ID: 28601834
[TBL] [Abstract][Full Text] [Related]
40. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
